國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Improving antibiotic production in S...

Karoonuthaisiri, Nitsara.

Improving antibiotic production in Streptomyces coelicolor.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Improving antibiotic production in Streptomyces coelicolor.
作者:	Karoonuthaisiri, Nitsara.
面頁冊數:	131 p.
附註:	Adviser: Camilla M. Kao.
附註:	Source: Dissertation Abstracts International, Volume: 65-09, Section: B, page: 4708.
Contained By:	Dissertation Abstracts International65-09B.
標題:	Engineering, Chemical.
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3145548
ISBN:	0496044990

Improving antibiotic production in Streptomyces coelicolor.
Karoonuthaisiri, Nitsara.

Improving antibiotic production in Streptomyces coelicolor. - 131 p.

Adviser: Camilla M. Kao.

Thesis (Ph.D.)--Stanford University, 2004.

Streptomyces bacteria produce the majority of antibiotics for the current pharmaceuticals market. Due to the central role of these bacteria in producing antibiotics, academic and industrial research groups have studied regulatory mechanisms of antibiotic synthesis, generated mutant strains with increased productivity, and developed strategies to generate novel bioactive molecules. In our laboratory, we use DNA microarrays of the model organism, Streptomyces coelicolor, to study the regulation of antibiotic production. Our ultimate goal is to engineer an antibiotic-overproducing bacterial strain.

ISBN: 0496044990Subjects--Topical Terms:

226989
Engineering, Chemical.

Improving antibiotic production in Streptomyces coelicolor.
LDR:02187nmm _2200265 _450 001 162884
005 20051017073533.5
008 090528s2004 eng d
020 $a 0496044990
035 $a 00149385
040 $a UnM $c UnM
100 0 $a Karoonuthaisiri, Nitsara. $3 228030
245 1 0 $a Improving antibiotic production in Streptomyces coelicolor.
300 $a 131 p.
500 $a Adviser: Camilla M. Kao.
500 $a Source: Dissertation Abstracts International, Volume: 65-09, Section: B, page: 4708.
502 $a Thesis (Ph.D.)--Stanford University, 2004.
520 # $a Streptomyces bacteria produce the majority of antibiotics for the current pharmaceuticals market. Due to the central role of these bacteria in producing antibiotics, academic and industrial research groups have studied regulatory mechanisms of antibiotic synthesis, generated mutant strains with increased productivity, and developed strategies to generate novel bioactive molecules. In our laboratory, we use DNA microarrays of the model organism, Streptomyces coelicolor, to study the regulation of antibiotic production. Our ultimate goal is to engineer an antibiotic-overproducing bacterial strain.
520 # $a This proof of concept study applied DNA microarrays to the goal of strain improvement. We simulated stress conditions that cells face in nature and identified conditions that increase the production of antibiotics. We found that stresses such as heat shock, phosphate upshift, and hyper-osmotic shift enhanced production; we then used DNA microarrays to identify gene expression changes during those stresses. We identified a putative antibiotic transporter, actII-ORF2, that plays a crucial role in antibiotic overproduction. Using this information, we have engineered a strain that produces over 34-fold more antibiotic compared to the wildtype strain.
590 $a School code: 0212.
650 # 0 $a Engineering, Chemical. $3 226989
690 $a 0542
710 0 # $a Stanford University. $3 212607
773 0 # $g 65-09B. $t Dissertation Abstracts International
790 $a 0212
790 1 0 $a Kao, Camilla M., $e advisor
791 $a Ph.D.
792 $a 2004
856 4 0 $u http://libsw.nuk.edu.tw:81/login?url=http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3145548 $z http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3145548